Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Multicenter, Double-Blind, Placebo Controlled Dose Ranging Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Efficacy of Obeldeivir (ODV) in Non-hospitalized Participants from Birth to< 5 with RSV

Upstate Medical University

Project: Research

Project Details

StatusActive
Effective start/end date03/5/25 → 03/4/27

Funding

  • Gilead Sciences Incorporated: $35,100.00